XPONANCE, INC. - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 115 filers reported holding ADMA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.

Quarter-by-quarter ownership
XPONANCE, INC. ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$47,907
-1.3%
13,382
+1.7%
0.00%0.0%
Q2 2023$48,546
+23.4%
13,156
+10.7%
0.00%0.0%
Q1 2023$39,339
-4.2%
11,885
+12.2%
0.00%0.0%
Q4 2022$41,085
+64.3%
10,589
+2.0%
0.00%
Q3 2022$25,000
+25.0%
10,381
+3.0%
0.00%
Q2 2022$20,00010,0820.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 8,793,321$32,447,35411.70%
Velan Capital Investment Management LP 2,726,051$10,059,1289.34%
Altium Capital Management LP 2,380,000$8,782,2006.65%
AWM Investment Company, Inc. 6,017,572$22,204,8413.01%
Caligan Partners LP 847,513$3,127,3231.76%
Perceptive Advisors 11,900,255$43,911,9411.27%
Mesirow Financial Investment Management, Inc. 51,686$190,7210.81%
OBERWEIS ASSET MANAGEMENT INC/ 1,668,700$6,157,5030.75%
TANG CAPITAL MANAGEMENT LLC 1,260,000$4,649,4000.68%
EAM Investors, LLC 883,842$3,261,3770.60%
View complete list of ADMA BIOLOGICS INC shareholders